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rotein kinase C (PKC) plays a prominent role in immune
signaling, and the paradigms for isoform selective
signaling are beginning to be elucidated. Real-time
microscopy was combined with molecular and biochemical
approaches to demonstrate a role for PKC-
 
 
 
 in Fc
 
 
 
 receptor
 
(Fc
 
 
 
R)–dependent phagocytosis. RAW 264.7 macrophages
were transfected with GFP-conjugated PKC isoforms,
and GFP movement was followed during phagocytosis of
ﬂuorescent IgG–opsonized beads. PKC-
 
 
 
, but not PKC-
 
 
 
,
concentrated around the beads. PKC-
 
 
 
 accumulation was
transient; apparent as a “ﬂash” on target ingestion. Similarly,
endogenous PKC-
 
 
 
 was speciﬁcally recruited to the nascent
phagosomes in a time-dependent manner. Overexpression
P
 
of PKC-
 
 
 
, but not PKC-
 
 
 
, PKC-
 
 
 
, or PKC-
 
 
 
 enhanced bead
uptake 1.8-fold. Additionally, the rate of phagocytosis in
GFP PKC-
 
 
 
 expressors was twice that of cells expressing
GFP PKC-
 
 
 
. Expression of the regulatory domain (
 
 
 
RD) and
the ﬁrst variable region (
 
 
 
V1) of PKC-
 
 
 
 inhibited uptake,
whereas the corresponding PKC-
 
 
 
 region had no effect. Actin
polymerization was enhanced on expression of GFP PKC-
 
 
 
and 
 
 
 
RD, but decreased in cells expressing 
 
 
 
V1, suggesting
 
that the 
 
 
 
RD and 
 
 
 
V1 inhibition of phagocytosis is not
due to effects on actin polymerization. These results
 
demonstrate a role for PKC-
 
 
 
 in Fc
 
 
 
R-mediated phagocytosis
that is independent of its effects on actin assembly.
 
Introduction
 
Ligation of macrophage Fc
 
 
 
 receptors (Fc
 
 
 
R)* elicits phago-
cytosis, pathogen killing, and gene activation. The involvement
of PKC in these processes is well documented, although less
is known about which PKC isoforms transduce the relevant
signals (Foreback et al., 1998; Korchak et al., 1998; Karimi
et al., 1999; Melendez et al., 1999; Dekker et al., 2000;
Kontny et al., 2000).
The PKC isoforms are divided into three families: (1)
 
cPKC-
 
 
 
, -
 
 
 
I, -
 
 
 
II, and -
 
 
 
 require Ca
 
2
 
 
 
, DAG, and phos-
 
phatidylserine (PS); (2) nPKC-
 
 
 
, -
 
 
 
, -
 
 
 
, and -
 
 
 
 require DAG
and PS; and (3) aPKC-
 
 
 
 and -
 
 
 
/
 
 
 
 require PS (Nishikawa et
al., 1997). All PKCs contain a unique regulatory and a
homologous catalytic domain, but have little substrate
specificity in vitro (Nishikawa et al., 1997). In cells, isoform-
selective PKC translocation occurs in response to stimuli,
suggesting that the regulatory domain contains critical
targeting information (Yedovitzky et al., 1997). Indeed,
isoform-specific docking proteins have been identified that
bind to the C2 region of the regulatory domain (Ron et al.,
1994; Prekeris et al., 1996; Csukai et al., 1997). Additionally,
the regulatory domain C1 region binds membrane lipids,
including DAG, arachidonic acid, and ceramide (Kashiwagi
et al., 2002). These results suggest that PKCs have multiple
mechanisms for membrane localization, but how these regions
direct PKCs to their site of action and lead to their activation
is not well understood. GFP-conjugated PKC isoforms have
been used extensively to probe signaling pathways in mam-
malian cells. These chimeras have enzymatic and activation
properties similar to their endogenous counterparts and
provide convenient readouts for PKC movement on cell
stimulation (Sakai et al., 1997; Ohmori et al., 1998; Shirai
et al., 1998; Wang et al., 1999).
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During IgG-dependent phagocytosis, molecules that trans-
locate to the phagosome are implicated in subsequent signal-
ing events. We have demonstrated that PKC-
 
 
 
, PKC-
 
 
 
, and
PKC-
 
 
 
 translocate to membranes during phagocytosis, and
PKC-
 
 
 
 and PKC-
 
 
 
 are present in phagosomes (Allen and Ad-
erem, 1995; Brumell et al., 1999; Larsen et al., 2000). That
PKC inhibitors block phagocytosis in monocytes and macro-
 
phage cell lines verifies their involvement in the ingestion pro-
cess (Zheleznyak and Brown, 1992; Karimi and Lennartz,
1998; Karimi et al., 1999; Larsen et al., 2000). Recently, we
reported that a cPKC is necessary for Fc
 
 
 
R-stimulated respi-
ratory burst, but that an nPKC is involved in phagocytosis
(Larsen et al., 2000). The present study identifies a role for
nPKC-
 
 
 
 in Fc
 
 
 
R-mediated phagocytosis.
 
Results and discussion
 
PKC-
 
 
 
 localizes to IgG-containing phagosomes
 
RAW 264.7 macrophages (RAW cells) express nPKCs-
 
 
 
 and
-
 
 
 
 (Larsen et al., 2000). Because it is involved in other actin-
based processes, we tested the hypothesis that PKC-
 
 
 
 is nec-
essary for IgG-mediated phagocytosis (Zeidman et al., 1999;
Berrier et al., 2000). Initially, GFP-conjugated PKC-
 
 
 
 and
-
 
 
 
 were visualized in fixed cells after synchronized phagocyto-
sis of Alexa 568–labeled IgG-opsonized glass beads (BIgG).
Three patterns were seen that predominated at different in-
gestion times (Fig. 1 A, 
 
 
 
;
 
 
 
depicted in a single cell at 10 min
of phagocytosis). Initially, PKC-
 
 
 
 accumulated at phago-
cytic cups (arrows); by 5 min, internalized beads with high
PKC-
 
 
 
 levels were detected (
 
 
 
). At 10 min, many targets
had lost the GFP concentration (asterisk). In contrast, the
distribution of GFP PKC-
 
 
 
 was not altered (Fig. 1 A, 
 
 
 
).
These results suggest that PKC-
 
 
 
 transiently associates with
targets, accumulating on particle binding and dissociating
after phagosome closure.
The localization of GFP PKC-
 
 
 
 in fixed cells was
confirmed by real-time imaging. PKC-
 
 
 
 accumulation
was seen as a “flash” as targets were ingested (Fig. 1 B, 
 
 
 
;
Video 1, available at http://www.jcb.org/cgi/content/full/
jcb.200205140/DC1). A localization time of 131 
 
 
 
 11 s
(
 
n
 
 
 
  
 
26, 4 experiments) was calculated from the first con-
centration of GFP until the signal returned to cytosolic
levels. GFP concentration preceded phagosome closure
and dispersed after ingestion. These observations are
consistent with a role for PKC-
 
 
 
 in phagocytosis. No
change in PKC-
 
 
 
 distribution was detected (Fig.1 B, 
 
 
 
;
Video 2, available at http://www.jcb.org/cgi/content/full/
jcb.200205140/DC1), although its translocation in re-
Figure 1. PKC- , but not PKC- , localizes to targets during 
IgG-mediated phagocytosis. (A) Transfectants expressing GFP-
conjugated PKC-  or PKC-  were incubated with Alexa 568 BIgG 
for 10 min, fixed, and analyzed by confocal microscopy. A Z series 
was taken and a single image was presented. (A) Top, merge of 
green and red. Bottom, pseudocolor highlighting the relative 
concentration of the GFP (cool colors   low concentrations, warm 
colors   higher concentrations). Left, Phagocytic cups (arrows) and 
newly formed phagosomes ( ) have accumulated PKC- , internalized 
particles have background levels (asterisk; n   10). Middle, GFP 
PKC-  does not concentrate around targets. Right, PMA (10  M, 
8 min) stimulates nuclear and plasma membrane localization of 
GFP PKC- . Inset, same cell before PMA. (B) Cells were transfected 
with GFP PKC-  ( ) or GFP PKC-  ( ). Images were taken at 10-s 
intervals after addition of BIgG (Videos 1 and 2). PKC-  panel 1, 
binding; panel 2, first accumulation; panel 3, ingestion complete; 
panel 4, loss of concentration. PKC-  panel 1, binding; panel 2, 
ingestion complete. Time for ingestion: PKC- , 49.43 s; PKC- , 
71.82 s. Total time that PKC-  is concentrated: 137.71 s. Evaluating 
the green signal alone facilitates determination of ingestion (PKC-  
panel 3, first frame in which bead is completely surrounded by 
green). PKC-  panel 4: pseudocolor demonstrating that PKC-  does 
not accumulate at targets (n   20). (C) Quantitation of ingestion 
rate. Time was calculated from first indentation of membrane to first 
frame in which target was surrounded by GFP. PKC- , n   49; PKC- , 
n   35; GFP, n   69 from 4–7 experiments. **, P   .001. Videos 1 
and 2 are available at http://www.jcb.org/cgi/content/full/
jcb.200205140/DC1. Figure 2. Localization of endogenous PKC-  and PKC-  during 
IgG-mediated phagocytosis. Synchronized phagocytosis was 
performed as described in Materials and methods. At varying times 
(0–10 min), phagocytosis was terminated, and nascent phagosomes 
and nonbead-associated membranes were recovered and subjected 
to immunoblot analysis for PKC- . The same membrane was then 
reprobed for PKC- . PKC-  translocates to nascent phagosomes in a 
time-dependent fashion. PKC-  is present in both phagosomes and 
membranes, and levels do not change. Data are representative of 
four experiments. Rat brain lysate was used as a positive control 
for the antibodies (  lane).PKC-  and IgG-dependent phagocytosis | Larsen et al. 941
sponse to PMA confirmed that the construct was func-
tional (Fig. 1 A,  -PMA).
To follow translocation of endogenous PKCs, we isolated
nascent phagosomes from untransfected cells at varying
times during synchronized phagocytosis. PKC-  levels were
elevated in 2.5–7.5-min phagosomes, but not in the non-
bead-associated membranes (Fig. 2). In contrast, PKC-  was
present in both phagosomes and membranes; a small (but
reproducible) increase was seen in membranes at 2.5 min,
but the level in phagosomes did not change (Fig. 2). These
results demonstrate that GFP-conjugated PKCs mimic their
endogenous isoforms with respect to Fc R-dependent trans-
location, and can be used as reporters for them.
Previously, we reported that PKC-  and PKC-  translo-
cate to (unfractionated) membranes during phagocytosis
(Larsen et al., 2000). Figs. 1 and 2 reveal that the increase in
membrane levels occurs at the phagosome for PKC-  and at
the nonbead-associated membranes for PKC- . Thus, PKC- 
may be involved in nonphagocytic Fc R signaling processes,
e.g., gene regulation. Indeed, that PMA stimulated nuclear
translocation of GFP PKC-  in our cells (Fig. 1 A,  -PMA)
is consistent with this hypothesis and published reports
(Wang et al., 1999).
Modulation of PKC-  alters IgG-mediated phagocytosis
To determine if PKC-  is involved in Fc R-mediated
phagocytosis, we quantified BIgG uptake in cells expressing
full-length GFP PKC- , PKC- , PKC- , or PKC- . Con-
trols received unconjugated GFP. Immunoblot analysis re-
vealed that PKC- , PKC- , and PKC-  were expressed at
levels 10-fold higher than the endogenous enzyme; PKC- 
expression increased fourfold (unpublished data). Only ex-
pression of GFP PKC-  increased ingestion. The enhance-
ment was 1.8-fold (Fig. 3, P   .001), similar to that ob-
tained on PMA/DAG treatment (Larsen et al., 2000). That
overexpression of PKC-  increased phagocytosis supports a
role for this isoform in phagocytosis. The fact that no other
isoform affected ingestion indicates that PKC overexpres-
sion, per se, does not modulate Fc R signaling.
The rate of phagocytosis was determined by subtracting
the time of the first indentation of the membrane from that
at which the particle was encircled with GFP. Phagocytosis
in PKC-  and GFP overexpressors was 76   4 s/bead and
80   5 s/bead, respectively, but 35   2 s/bead for PKC- 
(Fig. 1 C). Thus, beads were taken up twice as fast in the
PKC-  versus the GFP or PKC-  overexpressors (P   .001),
resulting in the enhancement seen in Fig. 3.
Inhibitory fragments of PKC-  depress phagocytosis
The first variable region of PKC-  and PKC-  ( V1 and
 V1) associates with PKC docking proteins on membranes,
preventing binding of the full length enzyme and acting as
isoform-specific inhibitors (Hundle et al., 1997; Yedovitzky
et al., 1997; Mochly-Rosen and Gordon, 1998; Zeidman et
al., 1999). We determined the effect of expression of GFP-
 V1 and  V1 on phagocytosis in RAW cells. Although ex-
pressed at equivalent levels (unpublished data), phagocytosis
was decreased 50% in cells expressing  V1 compared with
GFP controls; uptake in  V1 expressors was not different
from GFP alone (Fig. 4).
We also tested the regulatory domain fragment of PKC- 
( RD) for its effects on phagocytosis. This domain is neces-
sary and sufficient for neurite extension (Zeidman et al.,
1999). If neurite and pseudopod extension are similar,  RD
should support phagocytosis. Alternatively, if catalytic activ-
ity is necessary,  RD should block localization of the intact
PKC-  and inhibit phagocytosis. Transfectants expressing
 RD had significantly lower phagocytosis than those ex-
pressing unconjugated GFP or GFP  V1 (Fig. 4). Addition-
ally,  RD localized to phagocytic cups (Fig. 4 B). These
findings suggest that the catalytic activity of PKC-  is neces-
sary for phagocytosis.
To determine if the inhibitory effects of  RD and  V1
were due to defects in actin assembly, we quantified phalloi-
Figure 3. Overexpression of PKC-  alters phagocytosis. RAW 
cells were transfected with GFP-conjugated PKC- , PKC- , PKC- , 
or PKC- . Unconjugated GFP was used as the control. Cells were 
incubated for 60 min with dextran-rhodamine–loaded EIgG, and 
phagocytosis was quantified in  100 transfected cells. Results are 
reported as the percentage of phagocytosis measured in cells 
expressing unconjugated GFP (n   3; *, P   .01). Transfection 
alone did not alter phagocytosis, as uptake in GFP controls was 
equivalent to that in untransfected cells (not depicted).
Figure 4. Expression of GFP-conjugated fragments depresses phago-
cytosis. Cells were transfected with plasmids encoding the V1 region 
of PKC-  ( V1) or PKC-  ( V1), or the regulatory domain of PKC-  
( RD). (A) Phagocytosis was performed as in Figure 3. (B) Confocal 
analysis of  RD and  V1 demonstrates that  RD concentrates at 
targets. Concentration of  V1 was not observed, possibly due to a 
rapid cycling to and from the membrane (n   3–9). *, P   .01.942 The Journal of Cell Biology | Volume 159, Number 6, 2002
din fluorescence at the phagocytic cup (Fig. 5). The accu-
mulation of actin was similar for GFP controls and cells ex-
pressing PKC-  and  V1. A substantial increase in actin was
detected in cells expressing GFP PKC- . However, despite
similar effects on phagocytosis, the actin accumulation in
 V1 expressors was significantly lower (P   0.02), and that
in  RD was significantly higher (P   0.04) than that in the
GFP-expressing controls. The fact that PKC-  and  RD
contain an actin-binding domain (Prekeris et al., 1996) is
consistent with their ability to accumulate actin. In contrast,
 V1 may block localization of endogenous PKC- , interfer-
ing with normal actin polymerization and resulting in de-
creased actin assembly. Together, these data suggest that the
inhibitory effect of  RD and  V1 is not due to effects on ac-
tin assembly. Rather, the results support the hypothesis that
the PKC-  regulatory domain localizes the catalytic domain
to phagosomes where it phosphorylates critical components
of the phagocytic machinery. This is consistent with reports
that PKC inhibitors block phagocytosis (Zheleznyak and
Brown, 1992; Larsen et al., 2000).
PKC-  and  RD localized only to the forming phago-
some, suggesting that specific interaction(s) that direct them
there. The  V1 fragment associates with phagocytic com-
plexes and inhibits phagocytosis, suggesting the regulation
of PKC-  translocation is dependent on the V1 region.
PKC-  may be recruited to the site of Fc R ligation by se-
lective protein–protein interactions.  -COP is a binding
protein for PKC-  (Csukai et al., 1997) and is necessary for
phagocytosis (Hackam et al., 2001). Thus, it may function
to direct PKC-  to the phagosome for propagation of the
phagocytic signal.
Because manipulation of PKC-  levels correlated with
partial inhibition of phagocytosis, it may not be the only iso-
form involved. RAW cells expressing dominant negative
PKC-  have impaired phagocytosis (Breton and Desco-
teaux, 2000). However, in our cells PKC-  enters the
phagosome  10 min after initiation of phagocytosis (un-
published data). By this time, PKC-  levels are decreasing
(Fig. 2), so it is possible that PKC-  mediates initial phago-
cytosis and PKC-  supports ingestion at later times.
Materials and methods
Materials
EDTA, EGTA, BSA, thimersol, ammonium persulfate, Triton X-100, su-
crose, DTT, DMSO, and NaOH were obtained from Sigma-Aldrich. Tris
base, SDS, CaCl2 and MgCl2 were purchased from Mallinckrodt Baker, Inc.
Construction of the GFP PKC plasmids has been described previously
(Ohmori et al., 1998; Shirai et al., 1998; Zeidman et al., 1999).
Buffers
HBSS
2 consists of the following: HBSS (Life Technologies) containing 4 mM
sodium bicarbonate, 10 mM Hepes, and 1.5 mM CaCl2 and MgCl2. Lysis
buffer consists of 25 mM Tris-HCl, pH 7.4, 0.25 M sucrose, 2.5 mM DTT,
and 2.5 mM EDTA (5 mM benzamidine, 50  g/ml leupeptin, 50  g/ml apro-
tinin, 50  g/ml trypsin inhibitor, 5  g/ml pepstatin, 1 mM phenylmethylsul-
fonyl fluoride, 20 mM NaF, 1 mM Na3VO4, 1 mM paranitrophenyl phos-
phate, and 5 mM imidazole; Sigma-Aldrich). DNA assay buffer consists of
2 M NaCl, 2 mM EDTA and 50 mM Na2HPO4. TBST consists of 50 mM Tris,
pH 7.5, 150 mM NaCl, 0.05% Tween 20 and 0.01% thimersol.
Cells
The RAW LacR/FMLPR.2 subclone of RAW 264.7 cells was received from
Dr. Steven Greenberg (Columbia University, New York, NY; Cox et al.,
1997). Cells were maintained in RPMI 1640 (GIBCO BRL), sodium pyru-
vate, nonessential amino acids, glutamate (BioWhittaker), and 10% new-
born calf serum (HyClone).
Transfections
Phagocytosis assays and confocal analysis on fixed cells were described
previously (Larsen et al., 2000). For real-time confocal experiments, 10
6
cells were plated onto 35-mm glass bottom plates (MatTek Corporation)
and transfected using 1  g of DNA (Larsen et al., 2000). Cells were imaged
24–30 h after transfection.
Targets
Phagocytosis in transfected cells was quantified using IgG-opsonized
erythrocytes (EIgG) loaded with dextran-rhodamine (Scott et al., 1990);
BIgG for nascent phagosome isolation were made as described previously
(Karimi and Lennartz, 1995). 5  g Alexa 568–conjugated BSA (Molecular
Probes, Inc.) was included in the BSA coating step for generation of fluo-
rescent BIgG.
Synthesis of dextran-rhodamine
2.4 g 10K dextran was dissolved in 20 ml DMSO in a Teflon-lined screw-
cap tube. 233 mg of rhodamine B isothiocyanate, 0.5 ml of ferric chloride
in 183 mg/ml acetylacetone, and 0.5 ml of ferric chloride in 210 mg/ml py-
ridine was added, and the mixture was heated at 120 C for 3 h. After cool-
ing, the solution was poured into 400 ml of 95% ethanol containing 10 g of
sodium acetate. The dextran–rhodamine conjugate settled out for 3 h and
was reprecipitated in 400 ml of 95% ethanol (at 10 C for 16 h), filtered, and
suction-dried. The product was dissolved in 30 ml of water and loaded onto
a 4   50-cm fine column (Sephadex G25; Amersham Biosciences). 20-ml
fractions were collected and analyzed for their spectra. Fractions 12–17
were pooled, lyophilized, and analyzed for dye content (by absorbance at
543 nm) and hexose content (phenol sulfuric acid method; Dubois et al.,
1956). 9.37 nmol rhodamine   4.4% per mg dextran was calculated.
Figure 5. Expression of PKC-  constructs alters actin assembly. 
Cells were transfected with PKC- ,   V1, GFP (control), PKC- ,  V1, 
or  RD and were subjected to synchronized phagocytosis for 2 min, 
fixed, and the actin was visualized with Alexa 660–phalloidin. (A) 
Actin accumulation in PKC-  (n   32) and  RD (n   33) cells was 
significantly higher than GFP controls (n   33). Expression of  V1 
(n   24) decreased actin assembly. PKC-  (n   29) and  V1 (n   25) 
levels were similar to GFP (n   33). *, P   0.05. (B) Visualization of 
PKC (green), actin (red), or targets (blue) in representative cells.PKC-  and IgG-dependent phagocytosis | Larsen et al. 943
Phagocytosis assays
Dextran-rhodamine–loaded EIgG were added to transfectants at a 10:1 ra-
tio. After 60 min, extracellular targets were lysed and the coverslips were
mounted using ProLong
® Antifade (Molecular Probes, Inc.). Targets were
counted in  100 transfected cells, and the phagoctyic index was calcu-
lated (Larsen et al., 2000). The results are normalized to cells expressing
unconjugated GFP. All measurements were made in triplicate on three or
more separate cell preparations. Data are expressed as the mean   SEM.
Comparisons were made by ANOVA.
For confocal analysis, BIgG (4/cell) were bound to transfected cells (15
min on ice). The cells were placed in a 37 C water bath and fixed at 2.5–
10 min. The coverslips were mounted onto slides and imaged as described
previously (Larsen et al., 2000).
Nascent phagosomes
Cells were plated in 10-cm dishes and used when 90% confluent ( 12  
10
6 cells/plate). Cells were washed with HBSS and chilled on ice. BIgG
(30/cell) were bound (15 min) and then warmed to 37 C for synchronized
phagocytosis. At the indicated times, cells were scraped into lysis buffer
and sonicated (2   20 s, 2-s pulses). The beads were allowed to settle 1 h
on ice. The supernatant was removed and the beads were washed once
with lysis buffer and then solubilized in SDS sample buffer. Nonbead-asso-
ciated membranes were recovered from the supernatant by ultracentrifuga-
tion. The resulting pellet was extracted with lysis buffer   1% Triton X-100.
SDS-PAGE was run on the nascent phagosomes (normalized for number of
beads) and nonbead-associated membranes (normalized for DNA; Labarca
and Paigen, 1980). After SDS-PAGE, the proteins were transferred to nitro-
cellulose for immunoblot analysis (Larsen et al., 2000). Primary antibody
(monoclonal, PKC-  and PKC- ; Transduction Laboratories; polyclonal,
anti-PKC- ; Santa Cruz Biotechnology, Inc.) was followed by secondary
antibody (goat anti–rabbit HRP; Santa Cruz Biotechnology, Inc.) or rabbit
anti–mouse HRP (Jackson ImmunoResearch Laboratories). Bands were de-
tected with SuperSignal ECL (Pierce Chemical Co.).
Phalloidin staining
Transfected cells were fixed after 2 min of synchronized phagocytosis
(Larsen et al., 2000), permeabilized (30 min, 0.1% Triton X-100 in 1% BSA
in PBS), and stained with 0.7  M Alexa 660–conjugated phalloidin (for 60
min at 22 C). Coverslips were washed in PBS, mounted, and imaged
(Larsen et al., 2000). Pixel density at the phagocytic cup was quantified us-
ing the Intervision 2D analysis program (Noran Instruments, Inc.), and was
normalized to the pixel density of an equivalent area of nontarget-associ-
ated membrane. Normalized data for 24–33 events/condition from four in-
dependent experiments were compared with GFP controls using the t test.
Online supplemental material
Phagocytosis of IgG-coated glass beads was followed with time using an
inverted confocal laser scanning fluorescence microscope (LSM 410; Carl
Zeiss MicroImaging, Inc.) with a heated stage and 40  oil objective. GFP
was visualized using 488-nm argon excitation and a 505–550 barrier filter;
Alexa 568 was detected using 543-nm HeNe excitation and a 560 long
pass barrier filter. For each experiment, the media was removed and re-
placed with 800  l HBSS
2 . 200  l HBSS
2  containing 2   10
6 BIgG was
added to each plate (4:1 target; macrophage). Cells expressing GFP-conju-
gated PKCs were located and BIgG were added. Data collection began
when the beads first contacted the cells. The GFP and Alexa images were
collected simultaneously at 10-s intervals for 10 min. Videos 1 and 2 rep-
resent more than 20 independent experiments with each isoform. Online
supplemental material available at http://www.jcb.org/cgi/content/full/
jcb.200205140/DC1.
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